Atria Wealth Solutions Inc. Purchases New Position in Danaher Co. (NYSE:DHR)

Atria Wealth Solutions Inc. acquired a new stake in shares of Danaher Co. (NYSE:DHRGet Rating) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 25,152 shares of the conglomerate’s stock, valued at approximately $7,382,000.

Other institutional investors have also recently added to or reduced their stakes in the company. US Asset Management LLC lifted its stake in shares of Danaher by 0.6% in the 1st quarter. US Asset Management LLC now owns 5,774 shares of the conglomerate’s stock valued at $1,694,000 after purchasing an additional 37 shares during the last quarter. Mairs & Power Inc. increased its holdings in shares of Danaher by 4.1% during the 4th quarter. Mairs & Power Inc. now owns 959 shares of the conglomerate’s stock valued at $316,000 after acquiring an additional 38 shares during the last quarter. Mutual Advisors LLC raised its stake in shares of Danaher by 0.7% in the 4th quarter. Mutual Advisors LLC now owns 5,792 shares of the conglomerate’s stock valued at $1,906,000 after acquiring an additional 40 shares in the last quarter. Encompass Wealth Advisors LLC lifted its holdings in Danaher by 1.9% in the 1st quarter. Encompass Wealth Advisors LLC now owns 2,292 shares of the conglomerate’s stock worth $672,000 after purchasing an additional 42 shares during the last quarter. Finally, Howe & Rusling Inc. grew its holdings in Danaher by 48.8% during the first quarter. Howe & Rusling Inc. now owns 128 shares of the conglomerate’s stock valued at $38,000 after purchasing an additional 42 shares during the last quarter. 77.27% of the stock is currently owned by institutional investors and hedge funds.

Danaher Trading Up 0.8 %

Shares of DHR stock opened at $290.42 on Monday. The firm has a fifty day moving average of $277.27 and a 200-day moving average of $269.54. The stock has a market cap of $211.26 billion, a price-to-earnings ratio of 34.21, a P/E/G ratio of 1.39 and a beta of 0.88. Danaher Co. has a 52-week low of $233.71 and a 52-week high of $333.96. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.32 and a current ratio of 1.75.

Danaher (NYSE:DHRGet Rating) last posted its quarterly earnings results on Thursday, July 21st. The conglomerate reported $2.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.35 by $0.41. Danaher had a net margin of 20.61% and a return on equity of 18.57%. The firm had revenue of $7.75 billion during the quarter, compared to analyst estimates of $7.29 billion. During the same quarter in the prior year, the business posted $2.46 earnings per share. The company’s quarterly revenue was up 7.4% compared to the same quarter last year. On average, equities research analysts forecast that Danaher Co. will post 10.4 earnings per share for the current fiscal year.

Insider Activity at Danaher

In other Danaher news, EVP Joakim Weidemanis sold 12,000 shares of the stock in a transaction on Monday, July 25th. The stock was sold at an average price of $271.13, for a total transaction of $3,253,560.00. Following the completion of the transaction, the executive vice president now directly owns 74,398 shares in the company, valued at $20,171,529.74. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, EVP Joakim Weidemanis sold 12,000 shares of the firm’s stock in a transaction on Monday, July 25th. The stock was sold at an average price of $271.13, for a total value of $3,253,560.00. Following the completion of the sale, the executive vice president now directly owns 74,398 shares in the company, valued at $20,171,529.74. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Walter G. Lohr sold 3,906 shares of the stock in a transaction dated Friday, July 22nd. The stock was sold at an average price of $273.84, for a total transaction of $1,069,619.04. Following the sale, the director now directly owns 12,115 shares in the company, valued at approximately $3,317,571.60. The disclosure for this sale can be found here. Insiders have sold a total of 40,906 shares of company stock valued at $11,823,179 in the last 90 days. 11.20% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on DHR shares. Royal Bank of Canada raised shares of Danaher from a “sector perform” rating to an “outperform” rating and upped their price objective for the stock from $299.00 to $310.00 in a report on Wednesday, June 1st. StockNews.com upgraded Danaher from a “buy” rating to a “strong-buy” rating in a research note on Friday, August 26th. Barclays increased their target price on Danaher from $290.00 to $310.00 in a research note on Friday, July 22nd. Evercore ISI dropped their price target on Danaher from $320.00 to $280.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 5th. Finally, KeyCorp reduced their price objective on Danaher from $345.00 to $325.00 and set an “overweight” rating for the company in a research report on Friday, July 22nd. One analyst has rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Buy” and an average price target of $320.73.

About Danaher

(Get Rating)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.

See Also

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRGet Rating).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.